Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
Esther LatresCarla J GreenbaumMaria L OyaskiColin M DayanHelen Martina ColhounJohn M LachinJay S SkylerMichael R RickelsSimi T AhmedSanjoy DuttaKevan C HeroldMarjana MarinacPublished in: Diabetes (2024)